chr6-87529647-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP5
The ENST00000369536.10(RARS2):c.773G>A(p.Arg258His) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000476 in 1,588,752 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R258C) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000369536.10 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RARS2 | NM_020320.5 | c.773G>A | p.Arg258His | missense_variant, splice_region_variant | 10/20 | ENST00000369536.10 | NP_064716.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RARS2 | ENST00000369536.10 | c.773G>A | p.Arg258His | missense_variant, splice_region_variant | 10/20 | 1 | NM_020320.5 | ENSP00000358549 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000280 AC: 70AN: 250136Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135544
GnomAD4 exome AF: 0.000482 AC: 693AN: 1436520Hom.: 0 Cov.: 26 AF XY: 0.000448 AC XY: 321AN XY: 716420
GnomAD4 genome AF: 0.000414 AC: 63AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74458
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | RARS2: PM2, PM3, PP1, PP3 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27061686, 29431110, 34717047, 33209735, 24047924) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 30, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 258 of the RARS2 protein (p.Arg258His). This variant is present in population databases (rs145297855, gnomAD 0.2%). This missense change has been observed in individual(s) with clinical features of RARS2-related conditions (PMID: 24047924, 33209735). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 215080). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Pontocerebellar hypoplasia type 6 Pathogenic:2Uncertain:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 30, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 20, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Nov 14, 2023 | PM3_Strong, PM1 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at